| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Revenue | $45.5M | +0.7% |
| Cost of Revenue | $13.0M | +10.9% |
| Gross Profit | $32.5M | -2.8% |
| R&D Expense | $21.9M | +20.5% |
| SG&A Expense | $51.3M | +31.8% |
| Operating Income | -$40.8M | -71.9% |
| Interest Expense | $7.5M | +1.6% |
| Net Income | -$47.1M | -30.5% |
| EPS (Basic) | -$1.91 |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $6.6M | -65.6% |
| Short-term Investments | $70.8M | -26.5% |
| Accounts Receivable | $7.5M | +5.5% |
| Inventory | $9.7M | +24.2% |
| Current Assets | $97.7M | -26.4% |
| Total Assets | $114.1M | -14.6% |
| Current Liabilities | $11.0M | +18.0% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$36.9M | -50.0% |
| Capital Expenditures | $603K | +57.0% |
| Investing Cash Flow | $23.8M | +127.9% |
| Financing Cash Flow | $490K | -99.5% |
| Free Cash Flow | -$37.5M | -50.1% |
| +12.0% |
| EPS (Diluted) | -$1.91 | +12.0% |
| Long-term Debt |
| $52.9M |
| +6.2% |
| Total Liabilities | $79.3M | +32.1% |
| Stockholders' Equity | $34.8M | -52.7% |